Research ExplorerScientific StaffKlaus Pantel Publications

Prof.Dr. ID: 66906

Klaus Pantel

graph of relations
Affiliations
401 - 450 out of 494Page size: 50

Publications

  1. 2012

  2. Zirkulierende Tumorzellen in Krebspatienten als neuer Biomarker

    Gorges, T., Riethdorf, S. & Pantel, K., 2012, In: J Onkologie. 7, p. 184-188 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2011

  4. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells

    Grabinski, N., Bartkowiak, K., Grupp, K., Brandt, B., Pantel, K. & Jücker, M., 12.2011, In: CELL SIGNAL. 23, 12, p. 1952-1960 9 p., 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.

    Kornfeld, J., Meder, S., Wohlberg, M., Friedrich, R., Rau, T., Riethdorf, L., Löning, T., Pantel, K. & Riethdorf, S., 04.01.2011, In: BRIT J CANCER. 104, 1, p. 138-145 8 p., 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.

    Roth, C., Pantel, K., Müller, V., Rack, B., Kasimir-Bauer, S., Janni, W. & Schwarzenbach, H., 2011, In: BMC CANCER. 11, p. 4

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.

    Hein, S., Müller, V., Köhler, N., Wikman, H., Krenkel, S., Streichert, T., Schweizer, M., Riethdorf, S., Assmann, V., Henningsen, M., Beck, K., Issa, R., Jänicke, F., Pantel, K. & Milde-Langosch, K., 2011, In: BREAST CANCER RES TR. 129, 2, p. 347-360 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Cell-free nucleic acids as biomarkers in cancer patients.

    Schwarzenbach, H., Hoon, D. S. B. & Pantel, K., 2011, In: NAT REV CANCER. 11, 6, p. 426-437 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Circulating cancer cells and their clinical applications.

    Diamandis, E. P., Pantel, K., Scher, H. I., Terstappen, L. & Lianidou, E., 2011, In: CLIN CHEM. 57, 11, p. 1478-1484 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Circulating microRNAs: promising breast cancer biomarkers - author´s response

    Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K. & Schwarzenbach, H., 2011, In: BREAST CANCER RES. 13, 1, p. 403

    Research output: SCORING: Contribution to journal › Newspaper articles › Transfer

  11. Circulating tumor cell isolation and diagnostics: toward routine clinical use.

    van de Stolpe, A., Pantel, K., Sleijfer, S., Terstappen, L. W., Toonder, D. & Jaap, M. J., 2011, In: CANCER RES. 71, 18, p. 5955-5960 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Circulating tumors cells as biomarkers: progress toward biomarker qualification.

    Danila, D. C., Pantel, K., Fleisher, M. & Scher, H. I., 2011, In: CANCER J. 17, 6, p. 438-450 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Clinical relevance and biology of circulating tumor cells.

    Bednarz, N., Alix-Panabières, C. & Pantel, K., 2011, In: BREAST CANCER RES. 13, 6, p. 228 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Controversies in clinical cancer dormancy.

    Uhr, J. W. & Pantel, K., 2011, In: P NATL ACAD SCI USA. 108, 30, p. 12396-12400 30.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.

    Harms-Effenberger, K., Borgen, E., Zu Eulenburg, C. G., Bartkowiak, K., Grosser, A., Synnestvedt, M., Kaaresen, R., Brandt, B., Nesland, J. M., Pantel, K. & Naume, B., 2011, In: BREAST CANCER RES TR. 125, 3, p. 729-738 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Detection of circulating tumor cells by RT-PCR significantly associated with poor prognosis in breast cancer.

    Zhang, L., Wu, G. & Pantel, K., 2011, In: BREAST CANCER RES TR. 130, 1, p. 359-364 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.

    Rink, M., Chun, F., Minner, S. J. P., Friedrich, M., Mauermann, O., Heinzer, H., Huland, H., Fisch, M., Pantel, K. & Riethdorf, S., 2011, In: BJU INT. 107, 10, p. 1668-1675 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.

    Sänger, N., Harms-Effenberger, K., Riethdorf, S., Viviane, V. H., Gauwerky, J., Wiegratz, I., Strebhardt, K., Kaufmann, M. & Pantel, K., 2011, In: INT J CANCER. 129, 10, p. 2522-2526 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

    Minner, S. J. P., Enodien, M., Sirma, H., Lübke, A., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., Brase, J. C., Liu, A. Y., Schlüter, H., Pantel, K., Schumacher, U., Bokemeyer, C., Steuber, T., Graefen, M., Sauter, G. & Schlomm, T., 2011, In: CLIN CANCER RES. 17, 18, p. 5878-5888 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.

    Schwarzenbach, H., Müller, V., Milde-Langosch, K., Steinbach, B. & Pantel, K., 2011, In: MOL BIOSYST. 7, 10, p. 2848-2854 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients.

    Schwarzenbach, H., Chun, F., Isbarn, H., Huland, H. & Pantel, K., 2011, In: J CANCER RES CLIN. 137, 5, p. 811-819 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients.

    Wimberger, P., Roth, C., Pantel, K., Kasimir-Bauer, S., Kimmig, R. & Schwarzenbach, H., 2011, In: INT J CANCER. 128, 11, p. 2572-2580 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Molecular mechanisms of metastasis.

    Hoon, D. S. B., Ferris, R., Tanaka, R., Chong, K. K., Alix-Panabières, C. & Pantel, K., 2011, In: J SURG ONCOL. 103, 6, p. 508-517 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.

    Janni, W., Vogl, F. D., Wiedswang, G., Synnestvedt, M., Fehm, T., Jückstock, J., Borgen, E., Rack, B., Braun, S., Sommer, H., Solomayer, E., Pantel, K., Nesland, J., Friese, K. & Naume, B., 2011, In: CLIN CANCER RES. 17, 9, p. 2967-2976 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

    Müller, V., Riethdorf, S., Rack, B., Janni, W., Fasching, P. A., Solomayer, E., Aktas, B., Kasimir-Bauer, S., Zeitz, J., Pantel, K., Fehm, T. & Group, DETECT. S., 2011, In: BREAST CANCER RES. 13, 4, p. 71 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Prospective multi-centre study to validate chromogenic in situ hybridisation for the assessment of HER2 gene amplification in specimens from adjuvant and metastatic breast cancer patients.

    Riethdorf, S., Hoegel, B., John, B., Ott, G., Fritz, P., Thon, S., Löning, T. & Pantel, K., 2011, In: J CANCER RES CLIN. 137, 2, p. 261-269 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Quantitative high-resolution genomic analysis of single cancer cells.

    Hannemann, J., Meyer-Staeckling, S., Kemming, D., Alpers, I., Joosse, S., Pospisil, H., Kurtz, S., Görndt, J., Püschel, K., Riethdorf, S., Pantel, K. & Brandt, B., 2011, In: PLOS ONE. 6, 11, p. 26362 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.

    Roth, C., Kasimir-Bauer, S., Pantel, K. & Schwarzenbach, H., 2011, In: MOL ONCOL. 5, 3, p. 281-291 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study.

    Karkera, J., Steiner, H., Li, W., Skradski, V., Moser, P. L., Riethdorf, S., Reddy, M., Puchalski, T., Safer, K., Prabhakar, U., Pantel, K., Qi, M. & Culig, Z., 2011, In: PROSTATE. 71, 13, p. 1455-1465 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.

    Vashist, Y., Kutup, A., Musici, S., Yekebas, E. F., Mina, S., Uzunoglu, F. G., Zehler, O., König, A., Cataldegirmen, G., Bockhorn, M., Harms-Effenberger, K., Kalinin, V., Pantel, K. & Izbicki, J. R., 2011, In: MOL CELL ONCOL. 34, 4, p. 281-288 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

    Lu, X., Mu, E., Wei, Y., Riethdorf, S., Yang, Q., Yuan, M., Yan, J., Hua, Y., Tiede, B. J., Lu, X., Haffty, B. G., Pantel, K., Massagué, J. & Kang, Y., 2011, In: CANCER CELL. 20, 6, p. 701-714 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2010

  33. Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells.

    Riethdorf, S. & Pantel, K., 2010, In: ANN NY ACAD SCI. 1210, p. 66-77

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

    Bednarz, N., Eltze, E., Semjonow, A., Rink, M., Andreas, A., Mulder, L., Hannemann, J., Fisch, M., Pantel, K., Weier, H-U. G., Bielawski, K. P. & Brandt, B., 2010, In: CLIN CANCER RES. 16, 13, p. 3340-3348 9 p., 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.

    Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K. & Schwarzenbach, H., 2010, In: BREAST CANCER RES. 12, 6, p. 90 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Circulating tumour cells in cancer patients: challenges and perspectives.

    Pantel, K. & Alix-Panabières, C., 2010, In: TRENDS MOL MED. 16, 9, p. 398-406 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

    Riethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., Hilfrich, J., Holms, F., Tesch, H., Eidtmann, H., Untch, M., von Minckwitz, G. & Pantel, K., 2010, In: CLIN CANCER RES. 16, 9, p. 2634-2645 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.

    Bartkowiak, K., Harms-Effenberger, K., Harder, S., Andreas, A., Buck, F., Peter-Katalinic, J., Pantel, K. & Brandt, B., 2010, In: J PROTEOME RES. 9, 6, p. 3158-3168 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

    Fehm, T., Müller, V., Aktas, B., Janni, W., Schneeweiss, A., Stickeler, E., Lattrich, C., Löhberg, C. R., Solomayer, E., Rack, B., Riethdorf, S., Klein, C., Schindlbeck, C., Brocker, K., Kasimir-Bauer, S., Wallwiener, D. & Pantel, K., 2010, In: BREAST CANCER RES TR. 124, 2, p. 403-412 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Increase in circulating microRNA levels in blood of ovarian cancer patients

    Roth, C., Kasimir-Bauer, S., Heubner, M., Pantel, K. & Schwarzenbach, H., 2010, Circulating nucleic acids in plasma and serum. Gahan, P. (ed.). 1. ed. Springer, Vol. Ad. Exp. Med. Biol.. p. 63-71

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  41. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.

    Müller, V., Alix-Panabières, C. & Pantel, K., 2010, In: EUR J CANCER. 46, 7, p. 1189-1197 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.

    Kalinina, T., Bockhorn, M., Kaifi, J., Thieltges, S., Güngör, C., Harms-Effenberger, K., Strelow, A., Reichelt, U., Sauter, G., Pantel, K., Izbicki, J. R. & Yekebas, E. F., 2010, In: INT J CANCER. 127, 8, p. 1931-1940 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Molecular analysis of the polymorphisms of thymidylate synthase on cell-free circulating DNA in blood of patients with advanced colorectal carcinoma.

    Schwarzenbach, H., Goekkurt, E., Pantel, K., Aust, D. E. & Stoehlmacher, J., 2010, In: INT J CANCER. 127, 4, p. 881-888 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.

    Müller, I., Wischnewski, F., Pantel, K. & Schwarzenbach, H., 2010, In: BMC CANCER. 10, p. 297

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. PSA and Prostate

    Schwarzenbach, H. & Pantel, K., 2010, PSA and Prostate: Circulating cell-free blood nucleic acids as a potential molecular marker for prostate cancer. Nova Science Publishers, p. 65-85

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  46. What's new on circulating tumor cells? A meeting report.

    Lianidou, E. S., Mavroudis, D., Sotiropoulou, G., Agelaki, S. & Pantel, K., 2010, In: BREAST CANCER RES. 12, 4, p. 307 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. 2009

  48. Bone marrow aspiration for disseminated tumor cell detection: a must-have test or is the jury still out?

    Scher, H. I. & Pantel, K., 2009, In: J CLIN ONCOL. 27, 10, p. 1531-1533 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Cancer micrometastases.

    Pantel, K., Alix-Panabières, C. & Riethdorf, S., 2009, In: NAT REV CLIN ONCOL. 6, 6, p. 339-351 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

    Schwarzenbach, H., Alix-Panabières, C., Müller, I., Letang, N., Vendrell, J-P., Rebillard, X. & Pantel, K., 2009, In: CLIN CANCER RES. 15, 3, p. 1032-1038 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.

    Riethdorf, S. & Pantel, K., 2009, In: BREAST CANCER RES. 11, 3, p. 10 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Clinical Relevance of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients

    Müller, V., Fehm, T., Janni, W., Gebauer, G., Solomayer, E. & Pantel, K., 2009, In: BREAST CARE. 4, 5, p. 333-338 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

    Schwarzenbach, H., Pantel, K., Kemper, B., Beeger, C., Otterbach, F., Kimmig, R. & Kasimir-Bauer, S., 2009, In: BREAST CANCER RES. 11, 5, p. 71 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.

    Slade M, J., Payne, R., Riethdorf, S., Ward, B., Zaidi S, A. A., Stebbing, J., Palmieri, C., Sinnett, H. D., Kulinskaya, E., Pitfield, T., McCormack, R. T., Pantel, K. & Coombes, R. C., 2009, In: BRIT J CANCER. 100, 1, p. 160-166 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...5 6 7 8 9 10 Next